Several recent papers have investigated how polymicrobial interactions in the cystic fibrosis (CF) lung influence antimicrobial efficacy, demonstrating that microbial metabolites produced by one pathogen can alter the antimicrobial killing of another pathogen.
Browsing: Clinical > Antimicrobial Resistance
A new analysis has suggested that the notion of ‘completing the course’ when taking antibiotics is not evidence-based and should be dropped as it may actually increase the risk of antibiotic resistance.
New research investigating the evolutionary origins of MRSA has suggested strains may have emerged long before methicillin was used in clinical practice.
Widespread use of antibiotics in pregnancy to eradicate Group B Streptococcus has reduced disease in babies, however, could bacteriophage therapy yield the same results but in a more selective manner?
After the WHO published data highlighting a concerning level of antibiotic resistance in strains of gonorrhoea, take a closer look at the three antibiotics currently in clinical trials for this pathogen.
The WHO has reported increasing drug resistance in gonorrhoea, with some cases untreatable by current antibiotics, and stated that new drugs are urgently required.
In our new regular column, author, Julie Kaiser, highlights exciting developments in the field of AMR – this month read more about the origins of AMR genes and the ‘producer hypothesis’.
In this interview with Patrick Harris, from the University of Queensland, we discuss his role in setting up and co-ordinating the MERINO trial, and his research on the use of genomics in clinical microbiology.
A new study has investigated the effects of commonly used topical antimicrobials on the skin microbiome, discovering that antibiotics have a major and long-lasting effect.
A team from Tel Aviv University have developed hybrid bacteriophage particles that may allow DNA transduction to new bacteria, expanding the range of currently used phages.